Market Closed - Euronext Amsterdam 16:38:02 30/04/2024 BST 5-day change 1st Jan Change
25.25 EUR -1.14% Intraday chart for Philips NV +32.16% +19.75%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
UBS Upgrades Koninklijke Philips to Neutral From Sell MT
PHILIPS : Deutsche Bank upgrades recommendation to 'hold CF
PHILIPS NV : Barclays reiterates its Buy rating ZD
PHILIPS NV : Deutsche Bank reaffirms its Neutral rating ZD
PHILIPS : UBS raises its recommendation CF
PHILIPS NV : Goldman Sachs maintains a Buy rating ZD
PHILIPS NV : Deutsche Bank withdraws its Sell rating ZD
PHILIPS NV : UBS from Sell to Neutral ZD
PHILIPS NV : JP Morgan from Sell to Neutral ZD
ROYAL PHILIPS : The Dutch giant now poised for much better times Alphavalue
PHILIPS NV : Barclays remains its Buy rating ZD
ROYAL PHILIPS : Litigation uncertainty no longer an overhang; Q1 profitability beat Alphavalue
Tech Rally Subsides as US Equity Futures Waver Pre-Bell MT
Top Premarket Gainers MT
PHILIPS NV : UBS reiterates its Sell rating ZD
Philips Settles US Sleep Therapy Litigation for $1.1 Billion; Reaffirms 2024 Comparable Sales Outlook MT
European shares hit two-week high; inflation data, Fed meeting in focus RE
PHILIPS NV : Receives a Buy rating from Goldman Sachs ZD
Transcript : Koninklijke Philips N.V., Q1 2024 Earnings Call, Apr 29, 2024
PHILIPS NV : JP Morgan reaffirms its Sell rating ZD
Philips: quarterly loss on heavy provision CF
Koninklijke Philips N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Royal Philips Affirms FY24 Sales Outlook MT
Philips: agreement on Respironics litigation CF
Philips Secures $1.1 Billion Settlement Deal for US Class Action Over Recalled Sleep Devices MT
Chart Philips NV
More charts
Koninklijke Philips N.V. is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The group leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Koninklijke Philips N.V. is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
25.54 EUR
Average target price
23.49 EUR
Spread / Average Target
-8.03%
Consensus
  1. Stock Market
  2. Equities
  3. PHIA Stock
  4. News Philips NV
  5. Philips to Incentivize Suppliers to Adopt Climate Targets in Decarbonization Push